Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weiqing Jing

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Acta Biochimica Et Biophysica Sinica|December 17, 2009
Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockadeJin Zheng, Weiqing Jing, Rimas J Orentas
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastomaBryon D Johnson, Weiqing Jing, Rimas J Orentas
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Induction of immunity to neuroblastoma early after syngeneic hematopoietic stem cell transplantation using a novel mouse tumor vaccineWeiqing Jing, Rimas J Orentas, Bryon D Johnson
Blood|February 3, 2009
Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memoryWeiqing Jing, Jill A Gershan, Bryon D Johnson
Journal of Thrombosis and Haemostasis : JTH|August 10, 2024
Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitorsYingyu Chen, Jing Li, Jocelyn A Schroeder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2013
Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myelomaTyce J Kearl, Weiqing Jing, Jill A Gershan, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cellsWeiqing Jing, Christina K Baumgartner, Feng Xue, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockadeWilliam H D Hallett, Weiqing Jing, William R Drobyski, et al.
Journal for Immunotherapy of Cancer|June 18, 2015
Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastomaJill A Gershan, Kristen M Barr, James J Weber, et al.
Blood|April 28, 2011
Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastomaWeiqing Jing, Xiaocai Yan, William H D Hallett, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Acta Biochimica Et Biophysica Sinica|December 17, 2009
Discovery of YB-1 as a new immunological target in neuroblastoma by vaccination in the context of regulatory T cell blockadeJin Zheng, Weiqing Jing, Rimas J Orentas
Journal of Immunotherapy (Hagerstown, Md. : 1997)|May 2, 2007
CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastomaBryon D Johnson, Weiqing Jing, Rimas J Orentas
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 24, 2007
Induction of immunity to neuroblastoma early after syngeneic hematopoietic stem cell transplantation using a novel mouse tumor vaccineWeiqing Jing, Rimas J Orentas, Bryon D Johnson
Blood|February 3, 2009
Depletion of CD4 T cells enhances immunotherapy for neuroblastoma after syngeneic HSCT but compromises development of antitumor immune memoryWeiqing Jing, Jill A Gershan, Bryon D Johnson
Journal of Thrombosis and Haemostasis : JTH|August 10, 2024
Evaluating clinically translatable conditioning for platelet gene therapy in murine hemophilia A with inhibitorsYingyu Chen, Jing Li, Jocelyn A Schroeder, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2013
Programmed death receptor-1/programmed death receptor ligand-1 blockade after transient lymphodepletion to treat myelomaTyce J Kearl, Weiqing Jing, Jill A Gershan, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Pre-existing anti-factor VIII immunity alters therapeutic platelet-targeted factor VIII engraftment following busulfan conditioning through cytotoxic CD8 T cellsWeiqing Jing, Christina K Baumgartner, Feng Xue, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 4, 2011
Immunosuppressive effects of multiple myeloma are overcome by PD-L1 blockadeWilliam H D Hallett, Weiqing Jing, William R Drobyski, et al.
Journal for Immunotherapy of Cancer|June 18, 2015
Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastomaJill A Gershan, Kristen M Barr, James J Weber, et al.
Blood|April 28, 2011
Depletion of CD25⁺ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastomaWeiqing Jing, Xiaocai Yan, William H D Hallett, et al.
Pageof 3